ArticleJournal of health monitoring2018
Selecting and defining indicators for diabetes surveillance in Germany.
Article in Journal of health monitoring, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- A Composite Indicator for Primary Diabetes Care: A Cross-Sectional Study in Hungary.Healthcare (Basel, Switzerland) · 2025Article
- Diabetes-related amputations in Germany: analysis of time trend from 2015 to 2022 and differences by area-level socioeconomic deprivation.Journal of health monitoring · 2024Article
- Relationships between the Structural Characteristics of General Medical Practices and the Socioeconomic Status of Patients with Diabetes-Related Performance Indicators in Primary Care.Healthcare (Basel, Switzerland) · 2024Article
- Article
- Sports activity patterns and cardio-metabolic health over time among adults in Germany: Results of a nationwide 12-year follow-up study.Journal of sport and health science · 2021Article
- Gestational diabetes in Germany: Development of screening participation and prevalence.Journal of health monitoring · 2021Article
- Diabetes mellitus and comorbidities - A cross-sectional study with control group based on nationwide ambulatory claims data.Journal of health monitoring · 2021Article
- The selection and definition of indicators in public health monitoring for the 65+ age group in Germany.Journal of health monitoring · 2019Article
- Secondary data in diabetes surveillance - co-operation projects and definition of references on the documented prevalence of diabetes.Journal of health monitoring · 2019Article
- Social inequality and diabetes mellitus - developments over time among the adult population in Germany.Journal of health monitoring · 2019Article
- Editorial: Diabetes surveillance in Germany - status and perspectives.Journal of health monitoring · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mainly because of the large number of people affected and associated significant health policy implications, the Robert Koch Institute (RKI) is developing a public health surveillance system using diabetes as an example. In a first step to ensure long-term and comparable data collection and establish efficient surveillance structures, the RKI has defined a set of relevant indicators for diabetes surveillance. An extensive review of the available literature followed by a structured process of consensus provided the basis for a harmonised set of 30 core and 10 supplementary indicators. They correspond to the following four fields of activity: (1) reducing diabetes risk, (2) improving diabetes early detection and treatment, (3) reducing diabetes complications, (4) reducing the disease burden and overall costs of the disease. In future, in addition to the primary data provided by RKI health monitoring diabetes surveillance needs to also consider the results from secondary data sources. Currently, barriers to accessing this data remain, which will have to be overcome, and gaps in the data closed. The RKI intentends to continuously update this set of indicators and at some point apply it also to further chronic diseases with high public health relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.